Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-07 Purchase |
2023-12-08 08:00 am |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer |
1,740 | $0.88 | $1,531 | 5,232,304 (Direct) |
View |
| 2023-11-30 Purchase |
2023-11-30 5:00 pm |
SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER |
5,000 | $0.9 | $4,500 | 5,000 (Direct) |
View |
| 2023-11-29 Purchase |
2023-11-30 08:00 am |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
11,000 | $0.8947 | $9,842 | 766,699 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-27 Tax Withholding |
2025-04-01 4:19 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra CHIEF MEDICAL OFFICER |
1,179 | $0 | 47,249 (Direct) |
View |
| 2024-12-18 Tax Withholding |
2024-12-31 5:49 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra CHIEF MEDICAL OFFICER |
9,072 | $0 | 48,428 (Direct) |
View |
| 2024-11-01 Option Award |
2024-11-05 4:41 pm |
N/A 2034-11-01 |
SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-13 5:00 pm |
N/A 2034-08-12 |
SAB Biotherapeutics Inc. | SABS | To Lucy See Remarks |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Polvino William James Director |
33,958 | $0 | 33,958 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | SKYLER JAY S Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe PRESIDENT |
50,975 | $0 | 50,975 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Lucera Erick Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director |
76,790 | $0 | 76,790 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Link David Charles Director |
29,305 | $0 | 29,305 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J CEO & EXECUTIVE CHAIRMAN |
35,700 | $0 | 35,700 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:30 pm |
N/A 2034-07-15 |
SAB Biotherapeutics Inc. | SABS | Giberson Scott Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2024-06-24 5:00 pm |
N/A 2033-11-06 |
SAB Biotherapeutics Inc. | SABS | Conley Mark William See Remarks |
0 | $0 | 25,000 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 5:00 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra CHIEF MEDICAL OFFICER |
140,000 | $0 | 140,000 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 4:55 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe PRESIDENT |
190,000 | $0 | 190,000 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 4:50 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER |
140,000 | $0 | 140,000 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 4:45 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER |
115,000 | $0 | 115,000 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 4:40 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J CEO & EXECUTIVE CHAIRMAN |
434,000 | $0 | 434,000 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
4,584,571 | $0 | 4,612,951 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
59,649 | $1000 | 4,612,951 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
4,584,571 | $0 | 4,612,951 (Indirect) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
59,649 | $1000 | 4,612,951 (Indirect) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director |
2,857,142 | $0 | 2,857,142 (Indirect) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director |
1,800 | $1000 | 2,857,142 (Indirect) |
View |
Ownership |
2023-11-22 4:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director |
0 | $0 | 2,861,342 (Indirect) |
View |
| 2023-11-13 Option Award(A) |
2023-11-15 9:10 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $1000 | 31,269 (Indirect) |
View |
| 2023-11-13 Option Award(A) |
2023-11-15 4:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
13,269 | $1000 | 31,269 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $0 | 99,499 (Indirect) |
View |
| 2023-11-13 Option Award |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $1000 | 99,499 (Indirect) |
View |
| 2023-11-10 Option Award |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
44,230 | $0 | 99,499 (Indirect) |
View |
| 2023-11-13 Exercise |
2023-11-14 4:08 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
13,269 | $0 | 117,499 (Direct) |
View |
| 2023-11-13 Option Award |
2023-11-14 4:08 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
13,269 | $1000 | 117,499 (Direct) |
View |
| 2023-11-10 Option Award |
2023-11-14 4:08 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
44,230 | $0 | 117,499 (Direct) |
View |
| 2023-10-30 Option Award |
2023-11-03 4:50 pm |
N/A 2033-10-30 |
SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER |
850,000 | $0 | 850,000 (Direct) |
View |
| 2023-10-23 Exercise |
2023-10-24 5:33 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
16,269 | $0 | 18,000 (Direct) |
View |
| 2023-10-23 Option Award |
2023-10-24 5:33 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
16,269 | $1000 | 18,000 (Direct) |
View |
| 2023-10-23 Exercise |
2023-10-24 5:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
16,269 | $0 | 18,000 (Indirect) |
View |
| 2023-10-23 Option Award |
2023-10-24 5:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
16,269 | $1000 | 18,000 (Indirect) |
View |
Ownership |
2023-10-10 4:24 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
0 | $0 | 2,805,366 (Direct) |
View |
Ownership |
2023-10-10 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
0 | $0 | 2,805,366 (Indirect) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:01 pm |
N/A 2033-04-03 |
SAB Biotherapeutics Inc. | SABS | Lucera Erick Director |
25,000 | $0 | 25,000 (Direct) |
View |